cbdMD, Inc. (NYSE American: YCBD) announced today the launch of Inferno Freeze, a high‑strength, full‑spectrum topical designed for athletes, fitness enthusiasts, and anyone seeking advanced recovery. The product combines breakthrough wellness science with professional‑grade strength, featuring a blend of cannabinoids and both cooling and heating botanicals for rapid relief and recovery.
Inferno Freeze is built on nano‑technology and the company’s most advanced full‑spectrum formula to date, delivering a rapid‑acting, high‑strength topical that targets muscle soreness, inflammation, and performance fatigue. The formulation is positioned to meet the demands of high‑performance users who require fast, effective recovery to stay at the top of their game.
CEO and CFO Ronan Kennedy said, “Inferno Freeze embodies our mission to merge innovation with performance. This product was designed with athletes and other high‑performing individuals in mind, providing the relief they need to perform, recover, and repeat.”
The launch expands cbdMD’s topicals line and complements its broader portfolio of ingestibles, pet products, functional mushrooms, and hemp‑derived beverages. By entering the high‑performance recovery market, cbdMD adds a new revenue stream that aligns with its science‑driven brand strategy and positions the company for growth in a niche yet expanding segment.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.